Phenotypic localization of distinct DC subsets in mouse Peyer Patch

Vaccine

Volumn 29, Issue 20, 2011, Pages 3655-3661

  Rochereau, Nicolas ^a   Verrier, Bernard ^b   Pin, Jean Jacques ^c   Genin, Christian ^a   Paul, Stéphane ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c DENDRITICS SAS   (France)

Author keywords

Antibodies; Dendritic cells; Mucosa; Rodent

Indexed keywords

CD209 ANTIGEN; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; GLYCOPROTEIN P 15095; LANGERIN; TOLL LIKE RECEPTOR 8;

ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; DENDRITIC CELL; IMMUNOFLUORESCENCE TEST; INTESTINE; MOUSE; NONHUMAN; PEYER PATCH; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 79955113667     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.012     Document Type: Article

References (42)

1. Alpan O., Rudomen G., Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 2001, 166:4843-4852.
2. Stagg A.J., Hart A.L., Knight S.C., Kamm M.A. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 2003, 52:1522-1529.
3. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367.
4. Mora J.R., Iwata M., Eksteen B., Song S., Junt T., Senman B., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314:1157-1160.
5. Dillon S.M., Rogers L.M., Howe R., Hostetler L.A., Buhrman J., McCarter M.D., et al. Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. J Immunol 2010, 184:6612-6621.
6. Katz D.E., DeLorimier A.J., Wolf M.K., Hall E.R., Cassels F.J., van Hamont J.E., et al. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine 2003, 21:341-346.
7. Mishra N., Tiwari S., Vaidya B., Agrawal G.P., Vyas S.P. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target 2011, 19:67-68.
8. Butts C., Murray N., Maksymiuk A., Goss G., Marshall E., Soulières D., et al. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. J Clin Oncol 2005, 23:6674-6681.
9. Mayr U.B., Haller C., Haidinger W., Atrasheuskaya A., Bukin E., Lubitz W., et al. Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun 2005, 73:4810-4817.
10. Lavelle E.C., Grant G., Pfuller U., O'Hagan D.T. Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract. J Drug Target 2004, 12:89-95.
11. Lavelle E.C., Grant G., Pusztai A., Pfüller U., O'Hagan D.T. Mucosal immunogenicity of plant lectins in mice. Immunology 2000, 99:30-37.
12. Tokuhara D., Yuki Y., Nochi T., Kodama T., Mejima M., Kurokawa S., et al. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci U S A 2010, 107:8794-8799.
13. Zhou B., Zhang Y., Wang X., Dong J., Wang B., Han C., et al. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice. Vaccine 2010, 28:6021-6027.
14. Tacket C.O., Pasetti M.F., Edelman R., Howard J.A., Streatfield S. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 2004, 22:4385-4389.
15. Samstein R.M., Perica K., Balderrama F., Look M., Fahmy T.M. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials 2008, 29:703-708.
16. Primard C., Rochereau N., Luciani E., Genin C., Delair T., Paul S., et al. Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells. Biomaterials 2010, 31:6060-6068.
17. Chang S., Cha H., Igarashi O., Rennert P.D., Kissenpfennig A., Malissen B., et al. Cutting edge: langerin+dendritic cells in the mesenteric lymph node set the stage for skin and gut immune system cross-talk. J Immunol 2008, 180:4361-4365.
18. Anosova N.G., Chabot S., Shreedhar V., Borawski J.A., Dickinson B.L., Neutra M.R. Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol 2008, 1:59-67.
19. Iwasaki A., Kelsall B.L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000, 191:1381-1394.
20. Salazar-Gonzalez R.M., Niess J.H., Zammit D.J., Ravindran R., Srinivasan A., Maxwell J.R., et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 2006, 24:623-632.
21. Iwasaki A., Kelsall B.L. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001, 166:4884-4890.
22. Contractor N., Louten J., Kim L., Biron C.A., Kelsall B.L. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol 2007, 179:2690-2694.
23. Bilsborough J., George T.C., Norment A., Viney J.L. Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003, 108:481-492.
24. Duriancik D.M., Hoag K.A. The identification and enumeration of dendritic cell populations from individual mouse spleen and Peyer's patches using flow cytometric analysis. Cytometry Part A 2009, 75A:951-959.
25. Asselin-Paturel C., Brizard G., Pin J., Brière F., Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003, 171:6466-6477.
26. Salaun B., de Saint-Vis B., Clair-Moninot V., Pin J., Barthélemy-Dubois C., Kissenpfennig A., et al. Cloning and characterization of the mouse homologue of the human dendritic cell maturation marker CD208/DC-LAMP. Eur J Immunol 2003, 33:2619-2629.
27. Barois N., de Saint-Vis B., Lebecque S., Geuze H.J., Kleijmeer M.J. MHC class II compartments in human dendritic cells undergo profound structural changes upon activation. Traffic 2002, 3:894-905.
28. Colonna M., Trinchieri G., Liu Y. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004, 5:1219-1226.
29. Kadowaki N., Ho S., Antonenko S., de Waal Malefyt R., Kastelein R.A., Bazan F., et al. Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens. The Journal of Experimental Medicine 2001, vol. 194:863-870.
30. Dzionek A., Sohma Y., Nagafune J., Cella M., Colonna M., Facchetti F., et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin mediates antigen capture and is a potent inhibitor of interferon α/β induction. J Exp Med 2001, 194:1823-1834.
31. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001, 2:1144-1150.
32. Jameson B., Baribaud F., Pohlmann S., Ghavimi D., Mortari F., Doms R.W., et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and Rhesus Macaques. J Virol 2002, 76:1866-1875.
33. Geijtenbeek T.B.H., Torensma R., van Vliet S.J., van Duijnhoven G.C.F., Adema G.J., van Kooyk Y., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
34. Baribaud F., Pohlmann S., Sparwasser T., Kimata M.T.Y., Choi Y., Haggarty B.S., et al. Functional and antigenic characterization of human, Rhesus Macaque, Pigtailed Macaque, and Murine DC-SIGN. J Virol 2001, 75:10281-10289.
35. Kissenpfennig A., Ait-Yahia S., Clair-Moninot V., Stossel H., Badell E., Bordat Y., et al. Disruption of the langerin/CD207 gene abolishes birbeck granules without a marked loss of langerhans cell function. Mol Cell Biol 2005, 25:88-99.
36. Valladeau J., Ravel O., Dezutter-Dambuyant C., Moore K., Kleijmeer M., Liu Y., et al. Langerin, a novel c-type lectin specific to langerhans cells, is an endocytic receptor that induces the formation of birbeck granules. Immunity 2000, 12:71-81.
37. Chang S., Kweon M. Langerin-expressing dendritic cells in gut-associated lymphoid tissues. Immunol Rev 2010, 234:233-246.
38. de Witte L., Nabatov A., Pion M., Fluitsma D., de Jong M.A.W.P., de Gruijl T., et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007, 13:367-371.
39. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 2003, 171:3154-3162.
40. Bonnefont-Rebeix C., Marchal T., Bernaud J., Pin J., Leroux C., Lebecque S., et al. Toll-like receptor 3 (TLR3): a new marker of canine monocytes-derived dendritic cells (cMo-DC). Vet Immunol Immunopathol 2007, 118:134-139.
41. Bates E.E.M., Dieu M., Ravel O., Zurawski S.M., Patel S., Bridon J., et al. CD40L activation of dendritic cells down-regulates DORA, a novel member of the immunoglobulin superfamily. Mol Immunol 1998, 35:513-524.
42. Olweus J., BitMansour A., Warnke R., Thompson P.A., Carballido J., Picker L.J., et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A 1997, 94:12551-12556.